This is in line with recent data demonstrating that either DNMT3A or TET2 mutations together with FLT3-ITD alone are sufficient to transform murine HSC and induce AML in mouse models [49, 50]. This evidence concerns the gene DNMT3A and acute myeloid leukemia.